Literature DB >> 25475007

Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas.

Jung-Soo Pyo1, Young San Ko, Guhyun Kang, Dong-Hoon Kim, Woo Ho Kim, Byung Lan Lee, Jin Hee Sohn.   

Abstract

PURPOSE: Bile acids might induce mucin expression and regulate tumor behavior in esophageal and colon cancers. However, little is known about the effect of bile acids on tumor invasiveness of gastric carcinoma (GC). The aim of the current study was to elucidate the mechanisms by which bile acids regulate tumor invasion in GC.
METHODS: We investigated bile acid-induced MUC2 expression and cell invasion and migration in the cultured GC cell lines, SNU-216, and MKN45. In addition, immunohistochemical analysis of MUC2 and Snail was performed on 389 archival paraffin-embedded tissues of GC to evaluate the correlation of their expression with prognosis.
RESULTS: Deoxycholic acid (DCA), a secondary bile acid, had no effect on the viability of SNU-216 and MKN45 GC cells at low concentrations (0-100 μM), but decreased viability at a higher concentration (200 μM). MKN45 cells showed higher MUC2 expression than SNU-216 cells under basal conditions. DCA treatment upregulated MUC2 mRNA expression in both SNU-216 and MKN45 cells. Expression of Snail and MMP9 was markedly decreased by DCA treatment, and E-cadherin expression was subsequently increased. DCA significantly inhibited invasion and migration of SNU-216 and MKN45 cells. In human GC, MUC2 expression showed a negative correlation with Snail expression (P = 0.021) and a significantly positive correlation with better prognosis (P = 0.023).
CONCLUSIONS: Taken together, our data suggest that DCA induced MUC2 expression in GC cells and inhibited tumor invasion and migration. Additionally, MUC2-expressing GCs showed low rates of Snail expression and were associated with a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25475007     DOI: 10.1007/s00432-014-1890-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  41 in total

1.  Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase.

Authors:  Jung-Soo Pyo; Young San Ko; Woo Ho Kim; Manho Kim; Kwang-Woo Lee; Seon Young Nam; Hee-Yong Chung; Sung Jin Cho; Tai-Kyoung Baik; Byung Lan Lee
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

2.  Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis.

Authors:  Li Gong; Philip R Debruyne; Matthew Witek; Karl Nielsen; Adam Snook; Jieru E Lin; Alessandro Bombonati; Juan Palazzo; Stephanie Schulz; Scott A Waldman
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

Review 3.  Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.

Authors:  F De Vita; F Giuliani; N Silvestris; G Catalano; F Ciardiello; M Orditura
Journal:  Cancer Treat Rev       Date:  2010-11       Impact factor: 12.111

4.  Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.

Authors:  Kristina Roessler; Stefan-P Mönig; Paul-M Schneider; Franz-Georg Hanisch; Stephanie Landsberg; Juergen Thiele; Arnulf-H Hölscher; Hans-P Dienes; Stephan-E Baldus
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

5.  Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis.

Authors:  Maria J Redlak; Thomas A Miller
Journal:  Dig Dis Sci       Date:  2010-06-29       Impact factor: 3.199

6.  Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Authors:  Edaise M Silva; Maria D Begnami; José Humberto T G Fregnani; Adriane G Pelosof; Claudia Zitron; André L Montagnini; Fernando Augusto Soares
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

7.  Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.

Authors:  Kohei Wakatsuki; Yukishige Yamada; Michihiro Narikiyo; Masato Ueno; Tomoyoshi Takayama; Hidetoshi Tamaki; Katsuhiko Miki; Sohei Matsumoto; Koji Enomoto; Tomoyo Yokotani; Yoshiyuki Nakajima
Journal:  J Surg Oncol       Date:  2008-08-01       Impact factor: 3.454

8.  Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling.

Authors:  Maria J Redlak; Jacinda J Power; Thomas A Miller
Journal:  J Surg Res       Date:  2007-07-20       Impact factor: 2.192

Review 9.  Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior.

Authors:  Suguru Yonezawa; Masamichi Goto; Norishige Yamada; Michiyo Higashi; Mitsuharu Nomoto
Journal:  Proteomics       Date:  2008-08       Impact factor: 3.984

10.  Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions.

Authors:  Y Tajima; K Yamazaki; N Nishino; K Morohara; T Yamazaki; T Kaetsu; S Suzuki; M Kawamura; K Kumagai; M Kusano
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more
  13 in total

1.  MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis.

Authors:  Jung-Soo Pyo; Jin Hee Sohn; Guhyun Kang; Dong-Hoon Kim; Kyungeun Kim; In-Gu Do; Dong Hyun Kim
Journal:  J Pathol Transl Med       Date:  2015-05-15

2.  Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models.

Authors:  J P Phelan; F J Reen; N Dunphy; R O'Connor; F O'Gara
Journal:  BMC Cancer       Date:  2016-07-14       Impact factor: 4.430

3.  The role of bile acids in cellular invasiveness of gastric cancer.

Authors:  Yu-Chung Wu; Chang-Fang Chiu; Chung-Tzu Hsueh; Chung-Tsen Hsueh
Journal:  Cancer Cell Int       Date:  2018-05-21       Impact factor: 5.722

4.  Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4.

Authors:  Eleonóra Gál; Zoltán Veréb; Lajos Kemény; Dávid Rakk; András Szekeres; Eszter Becskeházi; László Tiszlavicz; Tamás Takács; László Czakó; Péter Hegyi; Viktória Venglovecz
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

5.  Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer.

Authors:  Il Hwan Oh; Jung-Soo Pyo; Byoung Kwan Son
Journal:  Curr Oncol       Date:  2021-08-19       Impact factor: 3.677

6.  Clinicopathological Significance and Prognostic Implications of REG4 Immunohistochemical Expression in Colorectal Cancer.

Authors:  Guhyun Kang; Ilhwan Oh; Jungsoo Pyo; Dongwook Kang; Byoungkwan Son
Journal:  Medicina (Kaunas)       Date:  2021-09-05       Impact factor: 2.430

Review 7.  Rethinking the bile acid/gut microbiome axis in cancer.

Authors:  John P Phelan; F Jerry Reen; Jose A Caparros-Martin; Rosemary O'Connor; Fergal O'Gara
Journal:  Oncotarget       Date:  2017-12-01

8.  Lactic Acid Bacteria May Impact Intestinal Barrier Function by Modulating Goblet Cells.

Authors:  Chengcheng Ren; Jelleke Dokter-Fokkens; Susana Figueroa Lozano; Qiuxiang Zhang; Bart J de Haan; Hao Zhang; Marijke M Faas; Paul de Vos
Journal:  Mol Nutr Food Res       Date:  2018-02-26       Impact factor: 5.914

Review 9.  Mucins, gut microbiota, and postbiotics role in colorectal cancer.

Authors:  Ramesh Pothuraju; Sanjib Chaudhary; Satyanarayana Rachagani; Sukhwinder Kaur; Hemant K Roy; Michael Bouvet; Surinder K Batra
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Diverse expression patterns of mucin 2 in colorectal cancer indicates its mechanism related to the intestinal mucosal barrier.

Authors:  Guo-Lian Gan; Hua-Tao Wu; Wen-Jia Chen; Chun-Lan Li; Qian-Qian Ye; Yi-Feng Zheng; Jing Liu
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.